What is Strand Life Sciences Pvt?
Headquartered in Bangalore, Strand Life Sciences Pvt operates at the intersection of advanced bioinformatics and clinical diagnostics. With over 25 years of industry experience, the firm provides a comprehensive suite of genomics solutions, including Next-Generation Sequencing (NGS) and PCR diagnostics. Their proprietary platform integrates artificial intelligence with real-world clinical data to drive biomarker discovery and oncology reporting. By serving a diverse clientele across the pharmaceutical, biotechnology, and academic sectors, Strand Life Sciences has established itself as a vital partner in the global effort to translate complex omics data into actionable clinical insights.
How much funding has Strand Life Sciences Pvt raised?
Strand Life Sciences Pvt has raised a total of $27.6M across 3 funding rounds:
Series A
$4.6M
Series B
$10M
Private Equity
$13M
Series A (2002): $4.6M with participation from Steamboat Ventures
Series B (2013): $10M, investors not publicly disclosed
Private Equity (2018): $13M supported by Quadria Capital Investment Management and HealthQuad
Key Investors in Strand Life Sciences Pvt
Quadria Capital Investment Management
A leading private equity firm based in India and Singapore, focused on transforming healthcare in Asia through strategic investments in scalable healthcare companies.
HealthQuad
India's leading healthcare innovation fund focused on nurturing models that transform healthcare and create an inclusive impact on communities.
Steamboat Ventures
A venture capital firm founded in 2000 that focuses on helping young companies become market leaders within the technology, media, and consumer sectors.
What's next for Strand Life Sciences Pvt?
With the recent influx of capital, Strand Life Sciences is well-positioned to accelerate its R&D initiatives and expand its footprint in the precision medicine market. The strategic focus will likely center on enhancing their AI-driven analytics capabilities and scaling their diagnostic services to meet the growing demand for personalized healthcare. As the company navigates its current lifecycle stage, the emphasis remains on maintaining compliance with international regulatory frameworks while fostering innovation in disease prevention and therapeutic development. This financial momentum provides the necessary runway to solidify their market leadership and drive long-term value for stakeholders in the evolving life sciences landscape.
See full Strand Life Sciences Pvt company page
